BTX-10908

N/A

Report date: 2024/08/07 10:11:41
NME

Base Information

Drug NameBTX-10908
Drug Alias NameBTX-10908
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsSon of sevenless homolog 1 degraders
TargetsGTPase KRasSon of sevenless homolog 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiotheryx Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A